Gadsden Properties's ROA from the second quarter of 2019 to the second quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Gadsden Properties's ROA in the second quarter of 2019?
Gadsden Properties, Inc. recorded a cumulative net loss of $-6 million during 12 months ending in the second quarter of 2019, resulting in a negative return on assets (ROA) of -16.51%.

However, within the Healthcare sector 310 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2019 quarter, so far to 3785, from total ROA ranking in the first quarter of 2019 at 4537.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter	(Dec 31 2018) IV. Quarter	(Sep 30 2018) III. Quarter	(Jun 30 2018) II. Quarter
Y / Y Total Assets Change	2385.92 %	-36.97 %	74.6 %	-61.87 %	-69.32 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-6	-4	-3	5	1
Return On Assets (TTM)	-16.51 %	-80.09 %	-60.95 %	105.24 %	16.85 %
FCRE's Total Ranking	# 3785	# 4537	# 4860	# 67	# 388
Total Assets (TTM) in million	134	4	3	5	5
Seq. Total Assets Change	3121.73 %	40.37 %	-44.62 %	-0.74 %	-18.31 %
Seq. Net Income Change	-	-	-	-	-

FCRE's 5 Years Annual ROA >> Back to FCRE Management Effectiveness >> Compare FCRE ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 102
Sector	# 311
Overall	# 3629

Return On Assets Statistics
High	Average	Low
84.22 %	-20.12 %	-141.69 %
(Sep 30 2018)		(Sep 30 2016)

Financial Statements
Gadsden Properties's Assets	$ 134 million	FCRE's Balance sheet
Gadsden Properties's Income	$ -3 million	Quarterly FCRE's Income Statement
FCRE's Income by Division		See FCRE's Income by Division

Annual Return On Assets	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	(Dec 31 2016) FY 2016	(Dec 31 2015) FY 2015	(Dec 31 2014) FY 2014
Y / Y Total Assets Change	-26.06 %	-69.74 %	-46.18 %	-81.69 %	-15.01 %
Total Assets in million	4	6	19	34	188
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-2	-19	-13	-35	-121
Annual Return On Assets	-50.39 %	-346.35 %	-71.69 %	-100.52 %	-64.71 %

FCRE's 5 Years Annual ROA >> Back to FCRE Management Effectiveness >> Compare FCRE ROA to its Competitors

More Return On Assets Ratios
FCRE's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FCRE's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FCRE's Competitors
Subscribers only: Roa for Gadsden Properties's Suppliers
Subscribers only: Return On Assets for FCRE's Customers

You may also want to know
FCRE's Roi	FCRE's Inventory Turnover Ratio	FCRE's Growth Rates	FCRE's Dividend Comparisons
	FCRE's Profitability Ratios	FCRE's Asset Turnover Ratio	FCRE's Dividend Growth
FCRE's Roe	FCRE's Valuation Ratios	FCRE's Financial Strength Ratios	FCRE's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2019, within Healthcare Sector

ROA

Date modified: 2026-08-29T17:32:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.